WuXi Biologics (Cayman) Inc. (WXXWY)
OTCMKTS · Delayed Price · Currency is USD
9.99
0.00 (-0.04%)
Sep 17, 2025, 3:52 PM EDT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of $20.50 billion as of September 18, 2025. Its market cap has increased by 259.40% in one year.
Market Cap
20.50B
Enterprise Value
20.03B
Revenue
2.80B
Ranking
n/a
PE Ratio
35.00
Stock Price
$9.99
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 4.11B to 20.50B, an increase of 398.97%. That is a compound annual growth rate of 21.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 20.33B | 119.05% |
| Dec 31, 2024 | 9.28B | -41.99% |
| Dec 29, 2023 | 16.00B | -50.63% |
| Dec 30, 2022 | 32.41B | -35.36% |
| Dec 31, 2021 | 50.14B | -7.43% |
| Dec 31, 2020 | 54.16B | 230.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Tian'an Technology Group | 792.01M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| CytoDyn | 351.92M |
| American Oncology Network | 345.48M |